by jlohrconsulting | Aug 23, 2025 | Uncategorized
Acta Diabetol. 2025 Aug 23. doi: 10.1007/s00592-025-02579-z. Online ahead of print. ABSTRACT AIMS: This study tested the hypothesis that the anti-diabetes drug dapagliflozin (DAPA) alleviates heart dysfunction induced by type 3 cardiorenal syndrome (CRS-3) by...
by jlohrconsulting | Aug 23, 2025 | Uncategorized
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 23. doi: 10.1007/s00210-025-04525-w. Online ahead of print. ABSTRACT Mirtazapine (MTZ) is a Food and Drug Administration-approved medication used primarily for the treatment of severe depression. It is a BCS class II drug...
by jlohrconsulting | Aug 23, 2025 | Uncategorized
Cogn Process. 2025 Aug 23. doi: 10.1007/s10339-025-01301-9. Online ahead of print. ABSTRACT Previous studies found that individuals with mental illness may have cognitive distortions. However, their findings are far from conclusive since most research focused on...
by jlohrconsulting | Aug 23, 2025 | Uncategorized
AIDS Behav. 2025 Aug 23. doi: 10.1007/s10461-025-04861-1. Online ahead of print. ABSTRACT Sexual and gender minority people (SGM) in Nigeria experience disproportionate HIV burden, with an HIV prevalence four to ten times higher than the national average. Better...
by jlohrconsulting | Aug 23, 2025 | Uncategorized
JA Clin Rep. 2025 Aug 23;11(1):46. doi: 10.1186/s40981-025-00809-5. ABSTRACT BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) often presents with a wide range of neurological symptoms, and atypical manifestations can complicate its diagnosis. We report...
by jlohrconsulting | Aug 23, 2025 | Uncategorized
Neurosci Bull. 2025 Aug 22. doi: 10.1007/s12264-025-01475-4. Online ahead of print. ABSTRACT Clinical studies have suggested that increased plasma oxytocin (OT) levels are a promising biomarker for bipolar disorder (BD), and our earlier post-mortem study found...
Recent Comments